In the expression analysis, we observed significant CPEB1 upregulation in 6 tumors, including pancreatic adenocarcinoma (PAAD) (tumor: -0.02 ± 1.29, normal tissue: -0.96 ± 1.27, p=4.1e-14), and significant downregulation in 26 tumors, including BC (tumor: -0.74 ± 1.47, normal tissue: 1.37 ± 0.94, p=9.4e-96) (Figure 5C). The gene discussed is CPEB1; the disease is pancreatic adenocarcinoma.